CHALFONT ST. GILES, UK -- 24 March 2014 -- GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher's HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and diagnostics in its growing Life Sciences business.
business unit
tags
TREVOSE, PA.---March 18, 2014---The American Fuel & Petrochemical Manufacturers (AFPM) Annual Meeting will take place March 23-25, 2014, in Orlando, Fla., and GE (NYSE: GE) will have experts from its water and process technologies business on-site to present two technical papers.